Physician profile
Michael W Brown
NPI 1962491092
$1,713.53
in general payments reported to CMS, 2019-2025
22 companies · $56.71 in 2025
The $56.71 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $445 · 2021: $260 · 2022: $91.97 · 2023: $13.46 · 2024: $14.40 · 2025: $56.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $349.81 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.68 | 2019-2020 | |
| Abbvie INC. | $229.66 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $172.41 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $166.96 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $119.93 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $97.33 | 2021-2022 | |
| Boston Scientific Corporation | $84.57 | 2023-2025 | Resolution 360 Ultra Clip, Rezum Generator |
| Ucb, INC. | $69.06 | 2019-2020 | |
| Allergan, INC. | $57.47 | 2019-2020 | |
| Biocompatibles, INC. | $44.86 | 2019 | |
| Concordia Pharmaceuticals INC. | $26.26 | 2019 | |
| Intercept Pharmaceuticals, INC. | $17.93 | 2020 | |
| Qol Medical, LLC | $14.61 | 2020 | |
| Shire North American Group INC | $13.93 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $11.06 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.